Iron-deficiency anaemia in the Emergency Room: A new opportunity for the use of intravenous iron

Blood Transfusion

Volumn 14, Issue 2, 2016, Pages 91-92

  Morhaim, Dan ^a,b,c   Auerbach, Michael ^d,e  

^a SINAI HOSPITAL OF BALTIMORE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c Maryland House of Delegates   (United States)

^d GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Private Practice   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; DIPHENHYDRAMINE; FERRITIN; IRON; TRANSFERRIN;

ANAPHYLAXIS; BLOOD CELL COUNT; BLOOD TRANSFUSION REACTION; CORTICOSTEROID THERAPY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; EMERGENCY MEDICINE; EMERGENCY WARD; ERYTHROCYTE TRANSFUSION; FERRITIN BLOOD LEVEL; GASTROINTESTINAL HEMORRHAGE; HOT FLUSH; HUMAN; INFUSION RELATED REACTION; IRON BLOOD LEVEL; IRON DEFICIENCY ANEMIA; IRON THERAPY; LEG SWELLING; MYALGIA; NAUSEA; TRANSFERRIN BLOOD LEVEL; UTERUS BLEEDING; HOSPITAL EMERGENCY SERVICE; INTRAVENOUS DRUG ADMINISTRATION; PREGNANCY COMPLICATIONS, HEMATOLOGIC;

ADMINISTRATION, INTRAVENOUS; ANEMIA, IRON-DEFICIENCY; EMERGENCY SERVICE, HOSPITAL; HUMANS; IRON; PREGNANCY COMPLICATIONS, HEMATOLOGIC;

EID: 84961680226     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2015.0204-15     Document Type: Editorial

References (12)

1. Quintana-Díaz M, Sara Fabra-Cadenas S, Gómez-Ramírez S et al. A fast-track anaemia clinic in the Emergency Department: feasibility and efficacy of intravenous iron administration for treating sub-acute iron deficiency anaemia. Blood Transfus 2016; 14: 126-33.
2. Chertow G, Mason P, Vaage-Nilsen O et al. Update on adverse drug events associated with parenteral iron. Nephrol Dial Transplant 2006; 21: 378-82.
3. Danielson B. Structure, chemistry and pharmacokinetics of intravenous iron agents. J Am Soc Nephrol 2004; 15 (Suppl. 2): S93-8.
4. Auerbach M, Coyne D, Ballard H. Intravenous iron: from anathema to standard of care. Am J Hematol 2008; 83: 580-8.
5. Jahn M, Andreasen H, Futterer S et al. A comparative study of the physicochemical properties of iron isomaltoside 1000 (Monofer), a new intravenous iron preparation and its clinical implications. Eur J Pharm Biopharm 2011; 78: 480-91.
6. Camaschella C. Iron-deficiency anemia. N Engl J Med 2015; 372: 1832-43.
7. Bircher A, Auerbach M. Hypersensitivity from intravenous iron products. Immunol Allergy Clin North Am 2014; 34: 707-23.
8. Auerbach M, Ballard H. Clinical use of intravenous iron: administration, efficacy, and safety. Hematology Am Soc Hematol Educ Program 2010; 2010: 338-47.
9. Garcia-Erce J, Curenca J, Muñoz M et al. Perioperative stimulation of erythropoiesis with intravenous iron and erythropoietin reduces transfusion requirements in patients with hip fracture. A prospective observational study. Vox Sang 2005; 88: 235-3.
10. Garcia-Erce J, Cuenca J, Martinez F et al. Perioperative intravenous iron preserves iron stores and may hasten the recovery from post-operative anaemia after knee replacement surgery. Transfus Med 2006; 16: 335-41.
11. Muñoz M, Naveira E, Seara J, et al. Role of parenteral iron in transfusion reqirements after total hip replacement. Transfus Med 2006; 16: 137-42.
12. Muñoz M, Campos A, Garcia-Erce J. Intravenous iron in colorectal surgery. Semin Hematol 2006; 43 (Suppl. 6): S36-8.